The anticancer multi-kinase inhibitor dovitinib also targets topoisomerase I and topoisomerase II

Brian B. Hasinoff, Xing Wu, John L. Nitiss, Ragu Kanagasabai, Jack C. Yalowich

Biochemical Pharmacology · 2012 · 55 citations · 34 references

Concepts

References

34